Dynamic R&D executive with a PhD in Biology and strong scientific foundations in oncological therapy. Over more than 20 years at HIPRA, I have progressed from researcher and project leader in Animal Health to creating and heading the Companion Animal R&D group. Since 2022, I serve as R&D Director for Human Health, driving the development of innovative vaccines and advanced technologies such as mRNA and lipid nanoparticle formulation. I bring a proven track record in building high‑performing multidisciplinary teams, steering complex projects, and shaping R&D strategy in a fast‑evolving biopharmaceutical environment.